The former leaders of two of the world’s largest generics companies have joined the board of Amneal Pharmaceuticals. Ex-Sandoz divisional head and CEO Jeff George has become a director on the US firm’s board, as has former Teva CEO Shlomo Yanai.
George led Sandoz for more than five years between December 2008 and April 2014 before moving on to lead Novartis’s...




